January/February 2015

Managing Care and Costs for Orphan Conditions

February 09, 2015

Features

The number of drugs approved for orphan conditions has increased in recent years, and specialty pharmacies play an important role in the management of therapies for patients with rare diseases.

Why a Holistic, Technology-Enabled Treatment Approach Is Necessary to Address Hepatitis C-Related Liver Disease

February 09, 2015

Features

Patients with hepatitis C benefit from a collaborative approach that involves specialty pharmacists and other care providers working with patients to promote patient engagement, adherence to therapy, and management of comorbidities.

Specialty Drugs: Year in Review 2014

February 09, 2015

Clinical Insights

In 2014, the FDA approved notable new therapies for the treatment of cancer, bleeding disorders, inflammatory conditions, cystic fibrosis, pulmonary fibrosis, HIV, hepatitis C, multiple sclerosis, angioedema, and other conditions.